cyc 202 has been researched along with Adenocarcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abaza, MS; Al-Attiyah, RJ; Bahman, AM | 1 |
| Cwiertka, K; Dzubak, P; Hajduch, M; Korinkova, G; Paprskarova, M | 1 |
| Andersen, JM; Caffrey, TC; Collisson, EC; Eggers, JP; Grandgenett, PM; High, RR; Hollingsworth, MA; Lewallen, ME; Ouellette, M; Singh, PK; Swanson, BJ; Tremayne, J | 1 |
| Amin, ND; Demelash, A; Linnoila, RI; McWhite, CD; Naizhen, X; Pant, HC; Rudrabhatla, P; Wang, X | 1 |
4 other study(ies) available for cyc 202 and Adenocarcinoma
| Article | Year |
|---|---|
Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Humans; Paclitaxel; Purines; Roscovitine; Time Factors; Vinblastine | 2008 |
The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.
Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Cell Cycle; Cyclin-Dependent Kinases; Flow Cytometry; Humans; Kinetin; Lung Neoplasms; Protein Kinase Inhibitors; Purines; Radiation-Sensitizing Agents; Roscovitine; Tumor Cells, Cultured; X-Rays | 2010 |
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Disease Progression; Enzyme Activation; Gene Amplification; Genes, ras; Humans; Mutation; Neoplasm Invasiveness; Nerve Tissue Proteins; Pancreatic Neoplasms; Purines; Roscovitine | 2011 |
Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 5; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histone-Lysine N-Methyltransferase; Humans; Lung Neoplasms; Neoplasm Invasiveness; Nerve Tissue Proteins; Purines; Roscovitine; Signal Transduction; Transcription Factors | 2012 |